Clinical Associate Professor, Internal Medicine, University of Maryland School of Medicine
Nephrology
Dr. Ravinder K. Wali, MD
|
|
Give Review
Dr. Ravinder K. Wali works in the field of Nephrology. He attended Government Medical College of Jammu and Kashmire. Dr. Ravinder K. Wali is also published. He has 37 publications published. The lastest publication: "Expression of G protein alpha subunits in normal rat colon and in azoxymethane-induced colonic neoplasms.' He accepts all Medicare patients.
Publications
- Efficacy and safety of carvedilol in treatment of heart failure with chronic Kidney disease: a meta-analysis of randomized trials.
- Aspirin and the prevention of cardiovascular disease in chronic Kidney disease: time to move forward?
- Minimizing the risk of Chronic allograft nephropathy.
- Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
- Polyomavirus BK versus JC replication and nephropathy in Renal transplant recipients: a prospective evaluation.
- Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient.
- Chronic Kidney disease: a risk factor for cardiovascular disease.
- Effect of Kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease.
- BK virus-associated nephropathy in Renal allograft recipients: rescue therapy by sirolimus-based immunosuppression.
- Retransplantation in patients With graft loss caused by polyoma virus nephropathy.
- Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells.
- The role of protein kinase-C alpha in the activation of particulate guanylate cyclase by 1 alpha,25-dihydroxyvitamin D3 in CaCo-2 cells.
- 1,25-dihydroxyvitamin D3 and TPA activate phospholipase D in Caco-2 cells: role of PKC-alpha.
- Expression of G protein alpha subunits in normal rat colon and in azoxymethane-induced colonic neoplasms.
- Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin...
- Renal amyloidosis in AIDS.
- HIV-1-associated nephropathy and Response to highly-active antiretroviral therapy.
- Hypertensive cardiovascular Disease in African Americans.
- Improved outcome of polyoma virus allograft nephropathy With early biopsy.
- Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft Nephropathy.
- Morphological spectrum of polyoma virus Disease in renal allografts: diagnostic accuracy of urine cytology.
- Optimizing immunosuppression With sirolimus in the first year posttransplantation: experience in the United States.
- Early Withdrawal of calcineurin inhibitors and rescue immunosuppression With sirolimus-based therapy in renal transplant recipients With moderate to severe renal dysfu...
- The decade of polyomavirus BK-associated Nephropathy: state of affairs.
- Negative impact of human leukocyte antigen matching in the outcome of polyomavirus Nephropathy.
- Efficacy and safety of renal tubule cell therapy for Acute renal failure.
- Histological patterns of polyomavirus nephropathy: correlation With graft outcome and viral load.
- Histological grading of Chronic pancreas allograft rejection/graft sclerosis.
- Cytomegalovirus-induced glomerular vasculopathy in Renal allografts: a report of two cases.
- Clinical course of polyoma virus nephropathy in 67 Renal transplant patients.
- BK polyoma virus allograft Nephropathy: ultrastructural features from viral cell entry to lysis.
- BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.
- Recent developments in toxic Nephropathy.
- Expression of NHERF-1, NHERF-2, PDGFR-alpha, and PDGFR-beta in normal human Kidneys and in renal transplant rejection.
- Cholesterol embolization Syndrome induced by thrombolytic therapy.
- Spontaneous cutaneous ulcers in a patient with a moderate degree of chronic Kidney disease: a different spectrum of calciphylaxis.
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Education
-
University of Maryland -
Georgetown University Hospital -
Government Medical College of Jammu and Kashmire
Hospital
-
Inova Fairfax Hospital -
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1821030933 | |
| NPPES Provider LastName | WALI | |
| NPPES Provider FirstName | RAVINDER | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 1995.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821030933 |
| Last Name Of The Provider | WALI |
| First Name Of The Provider | RAVINDER |
| View All |
Similar Doctors
|
|
Dr. Manuel Angoso, MD |
|
|
Dr. Y N. Yakub, MD |
|
|
Dr. Barry S. Strauch, MD |